One major benefit of taking injected GLP-1 medications is a sizeable reduction in risk for heart attacks, strokes and other ...

People take GLP-1 drugs like Wegovy, Ozempic, Mounjaro, and Zepbound for a variety of reasons, from controlling diabetes and ...

People who quit taking popular GLP-1 drugs such as Ozempic might their jeopardize heart health, according to a new study.

Research out today might provide even more of a reason for people to stay on GLP-1 medications like semaglutide, the active ...

While these policies are meant to control health care costs by steering patients toward lower-priced alternatives, they may ...

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 ...

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, ...

Jabs like Wegovy and Ozempic may cut the risk of life-threatening complications after a heart attack, researchers have ...

GLP‑1 weight‑loss drugs like Ozempic may help the heart heal after a heart attack, offering potential new treatment options, ...

Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

Clinical and payer strategies should treat GLP‑1 therapy as chronic for high-risk patients, addressing tolerability and cost ...